Dr Reddys Labs shares fall 1.37%; stock among top losers on Nifty 50

Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer

At 9:30 am on Monday, Dr Reddys Labs shares were trading at Rs 1,298.70, a decline of 1.37% on the NSE. The stock is among the top losers on the Nifty 50.

Among other top losers on the Nifty 50 were SBI Life Insurance, Cipla, Shriram Finance and TCS.

SBI Life Insura, Shriram Finance

SBI Life Insura shares were trading lower, with the stock priced at Rs 1,816.90, a 0.73% fall. Shriram Finance shares were trading at Rs 629.20, a fall of 0.58%.

Cipla

Cipla shares were down 0.62%, trading at Rs 1,564.80.

The company has shown consistent quarterly revenue growth, with the latest figure for June 2025 at Rs 6,957.47 Crore, compared to Rs 6,693.94 Crore in June 2024. Net profit for June 2025 stood at Rs 1,292.05 Crore.

Annually, Cipla’s revenue has increased steadily, reaching Rs 27,547.62 Crore in March 2025, up from Rs 25,774.09 Crore in March 2024. The net profit saw significant growth, reaching Rs 5,291.05 Crore in March 2025, compared to Rs 4,155.31 Crore in March 2024.

Basic EPS for March 2025 was Rs 65.29, compared to Rs 51.05 for March 2024. The company's Return on Net Worth (ROE) was 16.90% for March 2025, compared to 15.43% for March 2024.

Cipla has announced final dividends, including Rs 13.00 per share and a special dividend of Rs 3.00 per share, both effective June 27, 2025.

TCS

TCS shares were trading at Rs 3,118.00, a decline of 0.49%.

TCS has demonstrated consistent quarterly revenue, with June 2025 revenue at Rs 63,437.00 Crore. The net profit for June 2025 was Rs 12,819.00 Crore.

Annually, TCS has shown steady growth, with revenue reaching Rs 255,324.00 Crore in March 2025, up from Rs 240,893.00 Crore in March 2024. The net profit increased to Rs 48,797.00 Crore in March 2025, compared to Rs 46,099.00 Crore in March 2024.

Basic EPS for March 2025 was Rs 134.19. The company’s Return on Net Worth (ROE) was 51.24% for March 2025.

TCS has a history of bonus issues, with the last one being on April 19, 2018, in the ratio of 1:1.

Dr Reddys Labs shares were trading at Rs 1,298.70, a decline of 1.37% on the NSE.